abciximab (Q307088)

From Wikidata
Jump to navigation Jump to search
glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures
  • ReoPro
  • Reopro
  • Abciximac
  • c7E3
  • 7E3
  • C7E3
  • antiGPIIBIIIa
  • 7E3 antibody
edit
Language Label Description Also known as
English
abciximab
glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures
  • ReoPro
  • Reopro
  • Abciximac
  • c7E3
  • 7E3
  • C7E3
  • antiGPIIBIIIa
  • 7E3 antibody

Statements

462.149239 dalton
1 reference
C₂₂H₂₇ClN₄O₃S
1 reference
CC1=CC(=C(C=C1Cl)C)S(=O)(=O)N2CCC(CC2)C3=NC=CN3CC4=C(ON=C4C)C
1 reference
Reopro.jpg
308 × 419; 85 KB
0 references
Abciximab
0 references

Identifiers

1 reference
1-[(4-Chloro-2,5-dimethylphenyl)sulfonyl]-4-{1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-1H-imidazol-2-yl}piperidine (English)
21 September 2016
1 reference
28 October 2019
Abciximab (English)
10 May 2021
0 references
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit